Hepatitis C Virus Therapy
Findings from Toranomon Hospital advance knowledge in hepatitis C virus therapy
Published in Virus Weekly, October 2nd, 2007
Current study results from the report, "Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection," have been published. According to a study from Tokyo, Japan, "The aim of this study was to elucidate indicator of interferon (IFN) therapy for reducing hepatocellular carcinoma (HCC) in chronic hepatitis C patients without eradicating hepatitis C virus (HCV) RNA during IFN therapy. Inclusion criteria were biopsy-proven chronic hepatitis or liver cirrhosis, IFN period for more than 1.5 years and persistently positive HCV-RNA during IFN therapy."
"Two hundred thirty-six patients satisfied above criteria were treated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (2007-10-02)
More Articles from Virus Weekly
- Cancer Gene Therapy
T vs. B: Re-engineered Human T Cells Effectively Target and Kill Cancerous B Cells - Cancer Vaccines
M.D. Anderson-led team reports possible key to autoimmune disease - Chronic Fatigue Syndrome
Chronic fatigue syndrome linked to stomach virus - Enzyme Research
Scientists learn structure of enzyme in unusual virus - Nanotechnology
Scientists reveal DNA-enzyme interaction with first ever real time footage - Type 1 Diabetes
Immune police recognize good and bad guys in the body - More from this issue of Virus Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
